NCT02755142View on ClinicalTrials.gov

Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

June 30, 2001

Study Completion Date

June 30, 2001

Conditions
Brain Neoplasm
Interventions
BIOLOGICAL

Gliolan

All Listed Sponsors
collaborator

IKP

UNKNOWN

lead

medac GmbH

INDUSTRY

NCT02755142 - Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas | Biotech Hunter | Biotech Hunter